Skip to Content

Tag: WatchPAT

Also Noted

Itamar's WatchPAT gets nod from Blues

November 6, 2019HME News Staff

CAESAREA, Israel - Itamar Medical has received coverage for its WatchPAT as a home sleep apnea diagnostic test by Blue Shield of California (BSC) and the Blue Cross Blue Shield Federal Employee Plan (BCBS FEP). The inclusion of WatchPAT and PAT technology follows an assessment, Diagnosis and Medical Management of Obstructive Sleep Apnea Syndrome, recently released by Blue Cross Blue Shield Association Evidence Street. “The inclusion of WatchPAT as a recommended test for sleep apnea in the BCBS...

home sleep testing, Itamar Medical, sleep apnea, WatchPAT

Read Full Articlered right arrow icon

Also Noted

Itamar Medical: New fee schedule advances WatchPAT

November 16, 2018HME News Staff

CAESAREA, Israel - The recently released 2019 fee schedule from CMS should support broad use of Itamar Medical's WatchPAT technology, the company says. WatchPAT uses peripheral arterial tone (PAT) technology to provide cardiologists and sleep physicians in the United States with accurate sleep diagnoses. “We believe that the new CMS fee schedule validates the clinical value of our sleep tests for patients and may significantly advance utilization of our sleep tests in the U.S. market,”...

home sleep testing, Itamar Medical, WatchPAT

Read Full Articlered right arrow icon

Also Noted

Short takes: Breg, WatchPAT

August 4, 2016HME News Staff

Breg, an integrated solutions provider, announced the launch of Vision 5.0, the latest iteration of its DME workflow management software. Vision automates and optimizes in-house bracing and supplies programsÖThe FDA has approved WatchPAT, a home sleep test diagnostic device for sleep apnea, for use among patients as young as 12. The decision follows similar approvals in Japan and Europe, and expands the device's previous use in the U.S. for 17 and older.

Breg, WatchPAT